Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis

Archives of Internal Medicine

Volumn 160, Issue 2, 2000, Pages 159-164

  Meignan, Michel ^a   Rosso, Jean ^a   Gauthier, Hélène ^a   Brunengo, Françoise ^b   Claudel, Sophie ^b   Sagnard, Luc ^b   D'Azemar, Pascal ^b   Simonneau, Gérald ^c   Charbonnier, Bernard ^d  

^a HENRI MONDOR HOSPITAL   (France)

^b SANOFI   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

^d SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; HUMAN; INCIDENCE; LUNG EMBOLISM; LUNG PERFUSION; LUNG SCINTISCANNING; LUNG VENTILATION; MAJOR CLINICAL STUDY; PHLEBOGRAPHY; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY;

EID: 0034707687     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.2.159     Document Type: Review

References (35)

1. Dorfman GS, Cronan JJ, Tupper TB et al. Occult PE: a common occurrence in deep venous thrombosis. AJR Am J Roentgenol. 1987;148:263-266.
2. Huisman MV, Büller HR, ten Cate JW, et al. Unexpected high prevalence of silent PE in patients with deep venous thrombosis. Chest. 1989;95:498-502.
3. Partsch H, Oburger K, Mostbeck A, König B, Köhn H. Frequency of PE in ambulant patients with pelvic vein thrombosis: a prospective study. J Vasc Surg. 1992;16:715-722.
4. Moser KM, Fedullo PF, LitteJohn JK, Crawforrd R. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA. 1994;271:223-225.
5. Kalodiki E, Domjan J, Nicolaides AN, et al. V/Q defects and deep venous thrombosis following total hip replacement. Clin Radiol. 1995;50:400-403.
6. Lusiani L, Visona A, Bonanome A, Pesavento R, Zanco P. The characteristics of the thrombi of the lower limbs, as detected by ultrasonic scanning, do not predict PE. Chest. 1996;110:996-1000.
7. Partsch H, Kechavarz B, Mostbeck A, Köhn H, Lipp C. Frequency of PE in patients who have iliofemoral DVT and are treated with once-or twice-daily low-molecular-weight heparin. J Vasc Surg. 1996; 24:774-782.
8. Prandoni P, Lensing AW, Buller HR, et al. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet. 1992;339:441-445.
9. Koopman M, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractioned heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med. 1996;334:682-687.
10. Levine M, Gent M, Hirsch J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med. 1996;334:677-681.
11. Théry C, Simonneau G, Meyer G, et al. Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (Fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism: a dose-ranging study. Circulation. 1992;85:1380-1389.
12. The PIOPED Investigators. Value of the ventilation-perfusion scan in acute pulmonary embolism: results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA. 1990; 263:2753-2759.
13. Biello DR, Mahar AG, McKnight RC, Siegel BA. Ventilation-perfusion studies in suspected pulmonary embolism. AJR. 1979;133:1033-1037.
14. Stein PD. Terrin ML, Gottschalk A, Alavi A, Henry JW. Value of ventilation-perfusion scans versus perfusion scans alone in acute PE. Am J Cardiol. 1992;69:1239-1240.
15. Charbonnier BA, Fiessinger JN, Banga JD, Wenzel E, d'Azemar P, Sagnard L, on behalf of the FRAXODI group. Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. Thromb Haemost. 1998;79:897-901.
16. Stein PD, Henry JW, Gottschalk A. Small perfusion defects in suspected pulmonary embolism. J Nucl Med. 1996;37:1313-1316.
17. Worsley DF, Palevsky HI, Alavi A. A detailed evaluation of patients with acute pulmonary embolism and low-or very-low-probability lung scan interpretations. Arch Intern Med. 1994;154:2737-2741.
18. Gottschalk A, Juni JE, Sostman D, et al. Ventilation-perfusion scintigraphy in the PIOPED study, part I.: data collection and tabulation. J Nucl Med. 1993; 34:1109-1118.
19. Gottschalk A, Sostman HO, Coleman RE. Ventilation-perfusion scintigraphy in the PIOPED study. Part II Evaluation of the scintigraphic criteria and interpretations. J Nucl Med. 1993;34:1119-1126.
20. Sostman HD, Coleman RE, DeLong DM, Newman GE, Paine S. Evaluation of revised criteria for ventilation-perfusion scintigraphy in patients with suspected pulmonary embolism. Radiology. 1994; 193:103-107.
21. Worsley DF, Alavi A. Comprehensive analysis of the results of the PIOPED study. J Nucl Med. 1995; 36:2380-2387.
22. Hull RD, Hirsh J, Carter CJ, et al. Pulmonary angiography, ventilation lung scanning, and venograptiy for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med. 1983;98:891-899.
23. Hull RD, Hirsh J, Carter CJ, et al. Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism. Chest. 1985;88:819-828.
24. Stein PD, Henry JW, Gottschalk A. Mismatched vascular defects: an easy alternative to mismatched segmental equivalent defects for the interpretation of ventilation-perfusion lung scans in pulmonary embolism. Chest. 1993;104:1468-1472.
25. Worsley D, Kim CK, Alavi A, Palevsky HI. Detailed analysis of patients with matched ventilation-perfusion defects and chest radiographic opacities. J Nucl Med. 1993;34:1851-1853.
26. Monreal M, Ruiz J, Olazabal A, Arias A, Roca J. Deep venous thrombosis and the risk of pulmonary embolism: a systematic study. Chest. 1992; 102:677-681.
27. The Colombus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med. 1997; 337:657-662.
28. Simonneau G, Sors H, Charbonnier B, et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med. 1997;337:663-669.
29. Douketis J, Kearon C, Bates S, Duku E, Ginsberg J. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA. 1998;279:458-462
30. Goldhaber SZ. Pulmonary embolism. N Engl J Med. 1998;339:93-104.
31. Moser KM. Venous thromboembolism (state of the art). Am Rev Respir Dis. 1990;141:235-249.
32. Miniati M, Pistolesi M, Marini C, et al. Value of perfusion lung scan in the diagnosis of pulmonary embolism: results of the prospective investigative study of acute pulmonary embolism diagnosis (PISA-PED). Am J Respir Crit Care Med. 1996; 154:1387-1393.
33. Moser KM, Spragg RG, Utley J, Daily PO. Chronic thrombotic obstruction of major pulmonary arteries. Ann Intern Med. 1983;99:299-305.
34. Moser KM, Daily PO, Peterson KL, et al. Thromboendarterectomy for chronic, major vessel thromboembolic pulmonary hypertension in 42 patients: immediate and long-term results. Ann Intern Med. 1987;107:560-565.
35. Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med. 1999; 340:901-907.